封面
市場調查報告書
商品編碼
1067052

全球醫療保健分析市場預測(2022-2030 年)

Global Healthcare Analytics Market Forecast 2022-2030

出版日期: | 出版商: Inkwood Research | 英文 235 Pages | 商品交期: 2-3個工作天內

價格

預計 2022 年至 2030 年間,全球醫療保健分析市場將以 25.24% 的複合年增長率增長。市場增長的背後是對大數據不斷增長的需求,技術在降低醫療成本方面的作用,以及發展中國家和發達國家採用 HER 的激增。

本報告調查全球醫療保健分析市場,並提供有關市場規模和預測、市場動態、按細分市場和地區的市場分析、市場份額、競爭條件和戰略、關鍵公司概況等信息。

目錄

第一章調查範圍及調查方法

  • 調查目的
  • 調查範圍
  • 調查方法
  • 先決條件和限制

第2章執行摘要

  • 市場規模/估計
  • 市場概況

第三章市場動態

  • 主要促進者
    • 對大數據的需求增加
    • 新興國家和發達國家越來越多地採用 EHR
    • 技術降低醫療成本
  • 主要製約因素
    • 數據洩露次數增加
    • 安裝成本高
    • 精通技術的用戶

第四章主要分析

  • COVID-19 對市場的影響
  • 主要市場趨勢
  • 波特五力分析
  • 市場機會矩陣
  • 供應商情況
  • 主要購買標準
  • 價值鏈分析

第 5 章按類型劃分的市場

  • 描述性分析
  • 預測分析
  • 規範性分析

第 6 章按交付方式劃分的市場

  • 本地
  • 點播

第 7 章按組件劃分的市場

  • 服務
  • 軟件
  • 硬件

第 8 章使用市場

  • 財務分析
  • 臨床分析
  • 運營管理分析
  • 公共衛生分析

第 9 章最終用戶市場

  • 付款人
  • 提供者
  • ACO、HIE、MCO、TPA

第10章區域分析

  • 北美
  • 歐洲
  • 亞太地區
  • 其他領域

第11章競爭態勢

  • 主要戰略發展
    • 併購
    • 產品發布和開發
    • 合作夥伴關係和合同
  • 公司簡介
    • ALLSCRIPTS
    • CERNER
    • CVS HEALTH
    • ELSEVIER
    • HEALTH CATALYST
    • HMS (VITREOSHEALTH)
    • IBM CORPORATION
    • INOVALON
    • IQVIA
    • MCKESSON
    • MEDEANALYTICS
    • OPTUM
    • ORACLE
    • SAS INSTITUTE
    • VERISK ANALYTICS INC
Product Code: 22288

KEY FINDINGS

The global healthcare analytics market is forecasted to register a CAGR of 25.24% over the estimated years of 2022 to 2030. The market growth is credited to the increasing demand for big data, the role of technology in reducing healthcare costs, and the surging adoption of HER in developing as well as developed countries.

MARKET INSIGHTS

Healthcare analytics entails healthcare assessment activities undertaken as a result of information collected from various medical areas. These include pharmaceutical and research and development data, patient behavior and sentiment data, and clinical data.

Over recent years, the use of big data has rapidly increased, playing an essential role across numerous sectors, businesses, and governmental organizations. For instance, while manufacturers and transportation firms rely on big data for managing their supply chains and optimizing delivery routes, financial services companies use big data systems for real-time analysis of market data and risk management. Likewise, the use of big data across the healthcare industry facilitates the easier collection of real-time data, in addition to saving time. Besides, it bolsters healthcare marketing, as well.

REGIONAL INSIGHTS

The global healthcare analytics market growth evaluation comprises the assessment of the Asia-Pacific, North America, Europe, and Rest of World. The Asia-Pacific is projected to progress with the highest CAGR over the forecasted years. The growth of the regional market is accredited to the surging amount of complex data, the rise in government initiatives for increasing data analytics in the healthcare sector, and the rapid adoption of EHR.

COMPETITIVE INSIGHTS

The industrial rivalry within the global healthcare analytics market is intense. Furthermore, market leaders are attempting to develop data collection tools, healthcare analytics software, and others with the intent to supply these solutions worldwide.

Leading players operating in the market are IBM Corporation, Oracle, IQVIA, Inovalon, etc.

Our report offerings include:

  • Explore key findings of the overall market
  • Strategic breakdown of market dynamics (Drivers, Restraints, Opportunities, Challenges)
  • Market forecasts for a minimum of 9 years, along with 3 years of historical data for all segments, sub-segments, and regions
  • Market Segmentation cater to a thorough assessment of key segments with their market estimations
  • Geographical Analysis: Assessments of the mentioned regions and country-level segments with their market share
  • Key analytics: Porter's Five Forces Analysis, Vendor Landscape, Opportunity Matrix, Key Buying Criteria, etc.
  • Competitive landscape is the theoretical explanation of the key companies based on factors, market share, etc.
  • Company profiling: A detailed company overview, product/services offered, SCOT analysis, and recent strategic developments

TABLE OF CONTENTS

1. RESEARCH SCOPE & METHODOLOGY

  • 1.1. STUDY OBJECTIVES
  • 1.2. SCOPE OF STUDY
  • 1.3. METHODOLOGY
  • 1.4. ASSUMPTIONS & LIMITATIONS

2. EXECUTIVE SUMMARY

  • 2.1. MARKET SIZE & ESTIMATES
  • 2.2. MARKET OVERVIEW

3. MARKET DYNAMICS

  • 3.1. KEY DRIVERS
    • 3.1.1. INCREASED DEMAND FOR BIG DATA
    • 3.1.2. INCREASING ADOPTION OF EHR IN DEVELOPING AND DEVELOPED COUNTRIES
    • 3.1.3. TECHNOLOGY REDUCES HEALTHCARE COSTS
  • 3.2. KEY RESTRAINTS
    • 3.2.1. INCREASING NUMBER OF DATA BREACHES
    • 3.2.2. HIGH IMPLEMENTATION COSTS
    • 3.2.3. TECHNOLOGY-CHALLENGED USERS

4. KEY ANALYTICS

  • 4.1. IMPACT OF COVID-19 ON THE HEALTHCARE ANALYTICS MARKET
  • 4.2. KEY MARKET TRENDS
  • 4.3. PORTER'S FIVE FORCES ANALYSIS
    • 4.3.1. BUYERS POWER
    • 4.3.2. SUPPLIERS POWER
    • 4.3.3. SUBSTITUTION
    • 4.3.4. NEW ENTRANTS
    • 4.3.5. INDUSTRY RIVALRY
  • 4.4. OPPORTUNITY MATRIX
  • 4.5. VENDOR LANDSCAPE
  • 4.6. KEY BUYING CRITERIA
    • 4.6.1. QUALITY OF REPORTING
    • 4.6.2. SOFTWARE MUST BE PATIENT-FOCUSED
    • 4.6.3. DATA COLLECTION AND ANALYTICS TOOL
    • 4.6.4. COST-EFFECTIVENESS
  • 4.7. VALUE CHAIN ANALYSIS

5. MARKET BY TYPE

  • 5.1. DESCRIPTIVE ANALYTICS
  • 5.2. PREDICTIVE ANALYTICS
  • 5.3. PRESCRIPTIVE ANALYTICS

6. MARKET BY DELIVERY MODE

  • 6.1. ON-PREMISE
  • 6.2. ON-DEMAND

7. MARKET BY COMPONENT

  • 7.1. SERVICES
  • 7.2. SOFTWARE
  • 7.3. HARDWARE

8. MARKET BY APPLICATION

  • 8.1. FINANCIAL ANALYTICS
  • 8.2. CLINICAL ANALYTICS
  • 8.3. OPERATIONAL AND ADMINISTRATIVE ANALYTICS
  • 8.4. POPULATION HEALTH ANALYTICS

9. MARKET BY END-USER

  • 9.1. PAYER
  • 9.2. PROVIDER
  • 9.3. ACOS, HIES, MCOS, AND TPAS

10. GEOGRAPHICAL ANALYSIS

  • 10.1. NORTH AMERICA
    • 10.1.1. MARKET SIZE & ESTIMATES
    • 10.1.2. KEY GROWTH ENABLERS
    • 10.1.3. KEY CHALLENGES
    • 10.1.4. KEY PLAYERS
    • 10.1.5. COUNTRY ANALYSIS
      • 10.1.5.1. UNITED STATES
      • 10.1.5.2. CANADA
  • 10.2. EUROPE
    • 10.2.1. MARKET SIZE & ESTIMATES
    • 10.2.2. KEY GROWTH ENABLERS
    • 10.2.3. KEY CHALLENGES
    • 10.2.4. KEY PLAYERS
    • 10.2.5. COUNTRY ANALYSIS
      • 10.2.5.1. UNITED KINGDOM
      • 10.2.5.2. GERMANY
      • 10.2.5.3. FRANCE
      • 10.2.5.4. ITALY
      • 10.2.5.5. SPAIN
      • 10.2.5.6. NORDIC COUNTRIES
      • 10.2.5.7. RUSSIA
      • 10.2.5.8. REST OF EUROPE
  • 10.3. ASIA-PACIFIC
    • 10.3.1. MARKET SIZE & ESTIMATES
    • 10.3.2. KEY GROWTH ENABLERS
    • 10.3.3. KEY CHALLENGES
    • 10.3.4. KEY PLAYERS
    • 10.3.5. COUNTRY ANALYSIS
      • 10.3.5.1. CHINA
      • 10.3.5.2. JAPAN
      • 10.3.5.3. INDIA
      • 10.3.5.4. SOUTH KOREA
      • 10.3.5.5. INDONESIA
      • 10.3.5.6. VIETNAM
      • 10.3.5.7. AUSTRALIA & NEW ZEALAND
      • 10.3.5.8. REST OF ASIA-PACIFIC
  • 10.4. REST OF THE WORLD
    • 10.4.1. MARKET SIZE & ESTIMATES
    • 10.4.2. KEY GROWTH ENABLERS
    • 10.4.3. KEY CHALLENGES
    • 10.4.4. KEY PLAYERS
    • 10.4.5. REGIONAL ANALYSIS
      • 10.4.5.1. LATIN AMERICA
      • 10.4.5.2. MIDDLE EAST & AFRICA

11. COMPETITIVE LANDSCAPE

  • 11.1. KEY STRATEGIC DEVELOPMENTS
    • 11.1.1. MERGERS & ACQUISITIONS
    • 11.1.2. PRODUCT LAUNCHES & DEVELOPMENTS
    • 11.1.3. PARTNERSHIPS & AGREEMENTS
  • 11.2. COMPANY PROFILES
    • 11.2.1. ALLSCRIPTS
    • 11.2.2. CERNER
    • 11.2.3. CVS HEALTH
    • 11.2.4. ELSEVIER
    • 11.2.5. HEALTH CATALYST
    • 11.2.6. HMS (VITREOSHEALTH)
    • 11.2.7. IBM CORPORATION
    • 11.2.8. INOVALON
    • 11.2.9. IQVIA
    • 11.2.10. MCKESSON
    • 11.2.11. MEDEANALYTICS
    • 11.2.12. OPTUM
    • 11.2.13. ORACLE
    • 11.2.14. SAS INSTITUTE
    • 11.2.15. VERISK ANALYTICS INC

LIST OF TABLES

  • TABLE 1: MARKET SNAPSHOT - HEALTHCARE ANALYTICS
  • TABLE 2: GLOBAL HEALTHCARE ANALYTICS MARKET, BY TYPE, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)
  • TABLE 3: GLOBAL HEALTHCARE ANALYTICS MARKET, BY TYPE, FORECAST YEARS, 2022-2030 (IN $ MILLION)
  • TABLE 4: GLOBAL DESCRIPTIVE ANALYTICS MARKET, BY REGION, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)
  • TABLE 5: GLOBAL DESCRIPTIVE ANALYTICS MARKET, BY REGION, FORECAST YEARS, 2022-2030 (IN $ MILLION)
  • TABLE 6: GLOBAL PREDICTIVE ANALYTICS MARKET, BY REGION, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)
  • TABLE 7: GLOBAL PREDICTIVE ANALYTICS MARKET, BY REGION, FORECAST YEARS, 2022-2030 (IN $ MILLION)
  • TABLE 8: GLOBAL PRESCRIPTIVE ANALYTICS MARKET, BY REGION, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)
  • TABLE 9: GLOBAL PRESCRIPTIVE ANALYTICS MARKET, BY REGION, FORECAST YEARS, 2022-2030 (IN $ MILLION)
  • TABLE 10: GLOBAL HEALTHCARE ANALYTICS MARKET, BY DELIVERY MODE, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)
  • TABLE 11: GLOBAL HEALTHCARE ANALYTICS MARKET, BY DELIVERY MODE, FORECAST YEARS, 2022-2030 (IN $ MILLION)
  • TABLE 12: GLOBAL ON-PREMISE MARKET, BY REGION, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)
  • TABLE 13: GLOBAL ON-PREMISE MARKET, BY REGION, FORECAST YEARS, 2022-2030 (IN $ MILLION)
  • TABLE 14: GLOBAL ON-DEMAND MARKET, BY REGION, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)
  • TABLE 15: GLOBAL ON-DEMAND MARKET, BY REGION, FORECAST YEARS, 2022-2030 (IN $ MILLION)
  • TABLE 16: GLOBAL HEALTHCARE ANALYTICS MARKET, BY COMPONENT, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)
  • TABLE 17: GLOBAL HEALTHCARE ANALYTICS MARKET, BY COMPONENT, FORECAST YEARS, 2022-2030 (IN $ MILLION)
  • TABLE 18: GLOBAL SERVICES MARKET, BY REGION, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)
  • TABLE 19: GLOBAL SERVICES MARKET, BY REGION, FORECAST YEARS, 2022-2030 (IN $ MILLION)
  • TABLE 20: GLOBAL SOFTWARE HEALTHCARE MARKET, BY REGION, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)
  • TABLE 21: GLOBAL SOFTWARE HEALTHCARE MARKET, BY REGION, FORECAST YEARS, 2022-2030 (IN $ MILLION)
  • TABLE 22: GLOBAL HARDWARE MARKET, BY REGION, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)
  • TABLE 23: GLOBAL HARDWARE MARKET, BY REGION, FORECAST YEARS, 2022-2030 (IN $ MILLION)
  • TABLE 24: GLOBAL HEALTHCARE ANALYTICS MARKET, BY APPLICATION, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)
  • TABLE 25: GLOBAL HEALTHCARE ANALYTICS MARKET, BY APPLICATION, FORECAST YEARS, 2022-2030 (IN $ MILLION)
  • TABLE 26: GLOBAL FINANCIAL ANALYTICS MARKET, BY REGION, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)
  • TABLE 27: GLOBAL FINANCIAL ANALYTICS MARKET, BY REGION, FORECAST YEARS, 2022-2030 (IN $ MILLION)
  • TABLE 28: GLOBAL CLINICAL ANALYTICS MARKET, BY REGION, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)
  • TABLE 29: GLOBAL CLINICAL ANALYTICS MARKET, BY REGION, FORECAST YEARS, 2022-2030 (IN $ MILLION)
  • TABLE 30: GLOBAL OPERATIONAL AND ADMINISTRATIVE ANALYTICS MARKET, BY REGION, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)
  • TABLE 31: GLOBAL OPERATIONAL AND ADMINISTRATIVE ANALYTICS MARKET, BY REGION, FORECAST YEARS, 2022-2030 (IN $ MILLION)
  • TABLE 32: GLOBAL POPULATION HEALTH ANALYTICS MARKET, BY REGION, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)
  • TABLE 33: GLOBAL POPULATION HEALTH ANALYTICS MARKET, BY REGION, FORECAST YEARS, 2022-2030 (IN $ MILLION)
  • TABLE 34: GLOBAL HEALTHCARE ANALYTICS MARKET, BY END-USER, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)
  • TABLE 35: GLOBAL HEALTHCARE ANALYTICS MARKET, BY END-USER, FORECAST YEARS, 2022-2030 (IN $ MILLION)
  • TABLE 36: GLOBAL PAYER MARKET, BY REGION, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)
  • TABLE 37: GLOBAL PAYER MARKET, BY REGION, FORECAST YEARS, 2022-2030 (IN $ MILLION)
  • TABLE 38: GLOBAL PROVIDER MARKET, BY REGION, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)
  • TABLE 39: GLOBAL PROVIDER MARKET, BY REGION, FORECAST YEARS, 2022-2030 (IN $ MILLION)
  • TABLE 40: GLOBAL ACOS, HIES, MCOS, AND TPAS MARKET, BY REGION, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)
  • TABLE 41: GLOBAL ACOS, HIES, MCOS, AND TPAS MARKET, BY REGION, FORECAST YEARS, 2022-2030 (IN $ MILLION)
  • TABLE 42: GLOBAL HEALTHCARE ANALYTICS MARKET, BY GEOGRAPHY, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)
  • TABLE 43: GLOBAL HEALTHCARE ANALYTICS MARKET, BY GEOGRAPHY, FORECAST YEARS, 2022-2030 (IN $ MILLION)
  • TABLE 44: NORTH AMERICA HEALTHCARE ANALYTICS MARKET, BY COUNTRY, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)
  • TABLE 45: NORTH AMERICA HEALTHCARE ANALYTICS MARKET, BY COUNTRY, FORECAST YEARS, 2022-2030 (IN $ MILLION)
  • TABLE 46: LEADING PLAYERS OPERATING IN NORTH AMERICA HEALTHCARE ANALYTICS MARKET
  • TABLE 47: EUROPE HEALTHCARE ANALYTICS MARKET, BY COUNTRY, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)
  • TABLE 48: EUROPE HEALTHCARE ANALYTICS MARKET, BY COUNTRY, FORECAST YEARS, 2022-2030 (IN $ MILLION)
  • TABLE 49: LEADING PLAYERS OPERATING IN EUROPE HEALTHCARE ANALYTICS MARKET
  • TABLE 50: ASIA-PACIFIC HEALTHCARE ANALYTICS MARKET, BY COUNTRY, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)
  • TABLE 51: ASIA-PACIFIC HEALTHCARE ANALYTICS MARKET, BY COUNTRY, FORECAST YEARS, 2022-2030 (IN $ MILLION)
  • TABLE 52: LEADING PLAYERS OPERATING IN ASIA-PACIFIC HEALTHCARE ANALYTICS MARKET
  • TABLE 53: REST OF WORLD HEALTHCARE ANALYTICS MARKET, BY REGION, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)
  • TABLE 54: REST OF WORLD HEALTHCARE ANALYTICS MARKET, BY REGION, FORECAST YEARS, 2022-2030 (IN $ MILLION)
  • TABLE 55: LEADING PLAYERS OPERATING IN REST OF WORLD HEALTHCARE ANALYTICS MARKET
  • TABLE 56: LIST OF MERGERS & ACQUISITIONS
  • TABLE 57: LIST OF PRODUCT LAUNCHES & DEVELOPMENTS
  • TABLE 58: LIST OF PARTNERSHIPS & AGREEMENTS

LIST OF FIGURES

  • FIGURE 1: BIG DATA MARKET SIZE AND FORECAST, 2019-2025 (IN $ BILLION)
  • FIGURE 2: KEY MARKET TRENDS
  • FIGURE 3: PORTER'S FIVE FORCES ANALYSIS
  • FIGURE 4: OPPORTUNITY MATRIX
  • FIGURE 5: VENDOR LANDSCAPE
  • FIGURE 6: KEY BUYING CRITERIA
  • FIGURE 7: VALUE CHAIN ANALYSIS
  • FIGURE 8: GLOBAL HEALTHCARE ANALYTICS MARKET, GROWTH POTENTIAL, BY TYPE, IN 2021
  • FIGURE 9: GLOBAL HEALTHCARE ANALYTICS MARKET, BY DESCRIPTIVE ANALYTICS, 2022-2030 (IN $ MILLION)
  • FIGURE 10: GLOBAL HEALTHCARE ANALYTICS MARKET, BY PREDICTIVE ANALYTICS, 2022-2030 (IN $ MILLION)
  • FIGURE 11: GLOBAL HEALTHCARE ANALYTICS MARKET, BY PRESCRIPTIVE ANALYTICS, 2022-2030 (IN $ MILLION)
  • FIGURE 12: GLOBAL HEALTHCARE ANALYTICS MARKET, GROWTH POTENTIAL, BY DELIVERY MODE, IN 2021
  • FIGURE 13: GLOBAL HEALTHCARE ANALYTICS MARKET, BY ON-PREMISE, 2022-2030 (IN $ MILLION)
  • FIGURE 14: GLOBAL HEALTHCARE ANALYTICS MARKET, BY ON-DEMAND, 2022-2030 (IN $ MILLION)
  • FIGURE 15: GLOBAL HEALTHCARE ANALYTICS MARKET, GROWTH POTENTIAL, BY COMPONENT, IN 2021
  • FIGURE 16: GLOBAL HEALTHCARE ANALYTICS MARKET, BY SERVICES, 2022-2030 (IN $ MILLION)
  • FIGURE 17: GLOBAL HEALTHCARE ANALYTICS MARKET, BY SOFTWARE, 2022-2030 (IN $ MILLION)
  • FIGURE 18: GLOBAL HEALTHCARE ANALYTICS MARKET, BY HARDWARE, 2022-2030 (IN $ MILLION)
  • FIGURE 19: GLOBAL HEALTHCARE ANALYTICS MARKET, GROWTH POTENTIAL, BY APPLICATION, IN 2021
  • FIGURE 20: GLOBAL HEALTHCARE ANALYTICS MARKET, BY FINANCIAL ANALYTICS, 2022-2030 (IN $ MILLION)
  • FIGURE 21: GLOBAL HEALTHCARE ANALYTICS MARKET, BY CLINICAL ANALYTICS, 2022-2030 (IN $ MILLION)
  • FIGURE 22: GLOBAL HEALTHCARE ANALYTICS MARKET, BY OPERATIONAL AND ADMINISTRATIVE ANALYTICS, 2022-2030 (IN $ MILLION)
  • FIGURE 23: GLOBAL HEALTHCARE ANALYTICS MARKET, BY POPULATION HEALTH ANALYTICS, 2022-2030 (IN $ MILLION)
  • FIGURE 24: GLOBAL HEALTHCARE ANALYTICS MARKET, GROWTH POTENTIAL, BY END-USER, IN 2021
  • FIGURE 25: GLOBAL HEALTHCARE ANALYTICS MARKET, BY PAYER, 2022-2030 (IN $ MILLION)
  • FIGURE 26: GLOBAL HEALTHCARE ANALYTICS MARKET, BY PROVIDER, 2022-2030 (IN $ MILLION)
  • FIGURE 27: GLOBAL HEALTHCARE ANALYTICS MARKET, BY ACOS, HIES, MCOS AND TPAS, 2022-2030 (IN $ MILLION)
  • FIGURE 28: NORTH AMERICA HEALTHCARE ANALYTICS MARKET, COUNTRY OUTLOOK, 2021 & 2030 (IN %)
  • FIGURE 29: UNITED STATES HEALTHCARE ANALYTICS MARKET, 2022-2030 (IN $ MILLION)
  • FIGURE 30: CANADA HEALTHCARE ANALYTICS MARKET, 2022-2030 (IN $ MILLION)
  • FIGURE 31: EUROPE HEALTHCARE ANALYTICS MARKET, COUNTRY OUTLOOK, 2021 & 2030 (IN%)
  • FIGURE 32: UNITED KINGDOM HEALTHCARE ANALYTICS MARKET, 2021-2030 (IN $ MILLION)
  • FIGURE 33: GERMANY HEALTHCARE ANALYTICS MARKET, 2022-2030 (IN $ MILLION)
  • FIGURE 34: FRANCE HEALTHCARE ANALYTICS MARKET, 2022-2030 (IN $ MILLION)
  • FIGURE 35: ITALY HEALTHCARE ANALYTICS MARKET, 2022-2030 (IN $ MILLION)
  • FIGURE 36: SPAIN HEALTHCARE ANALYTICS MARKET, 2022-2030 (IN $ MILLION)
  • FIGURE 37: NORDIC COUNTRIES HEALTHCARE ANALYTICS MARKET, 2022-2030 (IN $ MILLION)
  • FIGURE 38: RUSSIA HEALTHCARE ANALYTICS MARKET, 2022-2030 (IN $ MILLION)
  • FIGURE 39: REST OF EUROPE HEALTHCARE ANALYTICS MARKET, 2022-2030 (IN $ MILLION)
  • FIGURE 40: ASIA-PACIFIC HEALTHCARE ANALYTICS MARKET, COUNTRY OUTLOOK, 2021 & 2030 (IN %)
  • FIGURE 41: CHINA HEALTHCARE ANALYTICS MARKET, 2021-2030 (IN $ MILLION)
  • FIGURE 42: JAPAN HEALTHCARE ANALYTICS MARKET, 2022-2030 (IN $ MILLION)
  • FIGURE 43: INDIA HEALTHCARE ANALYTICS MARKET, 2022-2030 (IN $ MILLION)
  • FIGURE 44: SOUTH KOREA HEALTHCARE ANALYTICS MARKET, 2022-2030 (IN $ MILLION)
  • FIGURE 45: INDONESIA HEALTHCARE ANALYTICS MARKET, 2022-2030 (IN $ MILLION)
  • FIGURE 46: VIETNAM HEALTHCARE ANALYTICS MARKET, 2022-2030 (IN $ MILLION)
  • FIGURE 47: AUSTRALIA & NEW ZEALAND HEALTHCARE ANALYTICS MARKET, 2022-2030 (IN $ MILLION)
  • FIGURE 48: REST OF ASIA-PACIFIC HEALTHCARE ANALYTICS MARKET, 2022-2030 (IN $ MILLION)
  • FIGURE 49: REST OF WORLD HEALTHCARE ANALYTICS MARKET, REGIONAL OUTLOOK, 2021 & 2030 (IN %)
  • FIGURE 50: LATIN AMERICA HEALTHCARE ANALYTICS MARKET, 2021-2030 (IN $ MILLION)
  • FIGURE 51: MIDDLE EAST & AFRICA HEALTHCARE ANALYTICS MARKET, 2022-2030 (IN $ MILLION)